How to treat Prostate cancer?

['Kayta uyarina']

¿Imaynataq próstata cancerta atipanku?

Kay unquyqa, maypichus kasqanta, maymanchus chayananta, ima unquywanchus unqusqanta ima qhawarispa, maymanchus rinanta ima qhawarispa ima, juk laya unquywan unqusqa runataqa, wakjinamanta qhawanku.

Kay tratamientostaqa ruwanku:

1. Qhawariy: Kay tratamientoqa, mana usqhayllatachu jampiyta qallarin, aswanpis sapa kuti qhawaywan, chantapis unquymanta allinta qhawan.

Kay tratamientoqa, prostata cancerniyuq qharispaq allin kanman.

2. Prostatitismanta sanoyachinapaq: Prostatitismanta sanoyachinapaq, prostata nisqa glándulata operanku.

Chaytaqa, chirurgiawan chayri laparoscopiawan (uj herramientawan) ruwanku.

3. Radioterapia: Kay tratamientoqa, cáncer unquywan unqusqa celulasta wañuchin.

Chaytaq, mana unquywan unqusqa kaqman churakunchu, manaqa, chay unquywan unqusqa kaqman churakun.

4. Hormonawan jampichikun: Kay tratamientoqa, qharipura khuru unquymanta jarkʼakun.

Kay tratamientoqa sapallanpi chayri waj tratamientoswan khuska apaykachakunman.

5. Quimioterapia: Kay tratamientoqa, cáncer unquywan unqusqa kaqkunata wañuchinapaq apaykachakun.

Kay tratamientoqa, próstata cancer kaqtin, chaytaq wak unquyman chayan chayqa, apaykachakunman.

6. Immunoterapia: Kay tratamientoqa, cáncer unquywan mana maqanakunanpaq, yanapakun.

Kay tratamientoqa, próstata cancer unquypaq, mana wak tratamientowan allinchakunchu.

7. Kay tratamientoqa, juk gen chayri proteína nisqaman chayan, chaytaq cáncer unquywan unqusqa kaqkunata wiñanankupaq yanapan.

Kay tratamientoqa, próstata cancer unquypaq, mana wak tratamientowan allinchakunchu.

8. Cryotherapy: Kay tratamientoqa, celulas cancerosas wañunanpaq, sinchi chiriwan juntʼachikun.

Kay tratamientoqa, próstata cancerpa qallariyninpi chayri waj tratamientoswan kutimusqanpi yanapan.

9.- Ultrasonido de alta intensidad (HIFU): Kay tratamientoqa, alto frecuencia sonorawan cancer celulakunata ruphaykun, chinkarichin ima.

Kay tratamientoqa, próstata cancerpa qallariyninpi chayri waj tratamientoswan kutimusqanpi yanapan.

10. Unquymanta qhaway: Kayqa, unquymanta qhawayta munan, sapa kuti qhawayta, ukhunchayta ima, mana unquymanta unquy rikhurinanpaqjinachu.

Chaytaq, machu runaspaq, próstata unquywan chayri wak unquykunawan allin kanman.

Kay unquymanta, mayqinchus aswan allin kasqanta yachanapaq, unquymanta qhawaqkunawan parlarina.

['Qillqasqa']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.

Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.

Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.

Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.

Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.

de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.

Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.

['Mana allinchu: unquy']

['Kay páginaqa, mana doctorman willanallapaqchu, nitaj ima unquymantapis jampichikunallapaqchu.']

['Kaypi willakusqanqa, mana unquykunata, unquykunata ima, yachanapaqchu, manaqa, unqusqasta yanapanapaq.']

['Kay tapuykunaman kutichiykunata churanapaq red neuronalqa, mana chiqanchu kachkan, chantapis yupaykunawan churanakun.']

["Kay sitio web nisqaqa mana ima unquymantapis jampichikunchu. BioMedLib, llamk'aqninkuna, manaqa kay sitio web nisqaman llamk'aqkuna, mana ima willaytapis, sut'ita chayri mana sut'ita, kaypi kaq willaykunata, apaykachayta ima, willankuchu."]

['Amachasqa: copyright']

['Kay Ley de Derechos de Autor del Milenio Digital de 1998, 17 U.S.C. § 512 (la DMCA) kamachiyqa, derechos de autorniyuqkunata, Internetpi kaqkuna, derechos de autor nisqata pʼakikusqankuta yuyaqkunata, jarkʼan.']

["Sichus allin yuyaywan yuyanki kay webpi utaq kay llamk'aykunapi ima qillqapas utaq ima llamk'achisqapas derechosniykita p'akikusqanta chayqa, qan (utaq wakichiqniykim) willawasunman chay qillqata utaq llamk'achisqata chinkachinanchikpaq utaq hark'ananchikpaq."]

['Kay willaykunataqa, qillqasqa, correo electrónico nisqapi apachina tiyan (contacto nisqapi, correo electrónico nisqapi qhaway).']

["DMCA kamachiypi nin, kay willañiqiman kaykunata churanan tiyan: 1) chay llamk'aypa sutinta, 2) chay llamk'aypa sutinta, imachus chay llamk'aypi kachkan chaymanta ima, 3) chay llamk'aypa maypi kasqanta, maymanchus kachkasqanta, imachus chay llamk'aypi kachkan chaymanta ima, 4) chay llamk'aypa sutinta, maymanchus kachkasqanta, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima."]

['(5) willayniykipi, mana chiqaqta willasqaykita, willayniykipi willasqaykikuna chiqap kasqanta, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis.']

['Kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi.']

['Mana tukuy kaykunata qillqaspaqa, mana usqhayllatachu kutichisunqa.']

['Rikuchikuy']

['Imallatapis tapuriyta chayri yuyaychayta munawaq chayqa, correo electróniconiykuman apachiwayku.']

How to treat prostate cancer?

There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.

Some common treatments include:

1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.

It may be suitable for men with low-risk prostate cancer.

2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.

It can be done through open surgery or laparoscopically (using small incisions and specialized tools).

3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.

It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).

4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.

It can be used alone or in combination with other treatments.

5. Chemotherapy: This treatment uses drugs to kill cancer cells.

It may be used for advanced prostate cancer that has spread to other parts of the body.

6. Immunotherapy: This treatment helps the immune system fight cancer.

It may be used for advanced prostate cancer that has not responded to other treatments.

7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.

It may be used for advanced prostate cancer that has not responded to other treatments.

8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.

It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.

9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.

It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.

10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.

It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.

It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.